Parallax Health Sciences Announces Increased Customer Acquisition in Both Management and Diagnostics Divisions
09 avr. 2020 10h10 HE
|
Parallax Health Sciences, Inc.
Company Receives Over $10 million of Telehealth and Medical Supply Contracts from Coast to Coast NEW YORK, NY, April 09, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health...
Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm® D for Medical and Critical Services Workers
07 avr. 2020 10h21 HE
|
Parallax Health Sciences, Inc.
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB:...
Parallax Announces International Medical Supply Chain Agreement for COVID-19 Testing Kits and FDA Registered Suppliers of Personal Protective Equipment (PPE)
30 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Joint Venture Procures from Established Manufacturers with Reliable Supply and Logistics for US Medical Operations NEW YORK, NY, March 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
Parallax Launches Secure Good Health Outcomes Telehealth Application for Immediate Free Download
25 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Parallax Announces Patented Telehealth Initiative to Help Healthcare Providers Better Communicate with Their Patients and Reduce ER Admissions NEW YORK, NY, March 25, 2020 (GLOBE NEWSWIRE) --...
Parallax Updates Progress on Proprietary COVID-19 Rapid Test
24 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Parallax Acquired Antigen And Antibodies Of COVID-19 Being Integrated Into Its Patented And FDA Approved Target Diagnostics Test Platform NEW YORK, New York, March 24, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Announces Immediate Availability Point-of-Care COVID-19 Diagnostic Testing Kits, Personal Protection Equipment (PPE) and Medical Supplies
23 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Company Benefits from Unique Chinese, Hong Kong, Macau Diagnostic Patent Rights, and Closes Deal to Help America Now NEW YORK, NY, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax...
Parallax Reaffirms Previously Released Statement
18 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
FDA Approved VT-1000 Qualitative and Quantitative Analyzer NEW YORK, New York, March 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or...
Harvard In Tech and Parallax Health Sciences to Present Live Webinar “COVID-19 Testing, Telehealth, Technology and Data Driven Solutions” Wednesday, March 18th at 1 PM EDT
17 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
NEW YORK, NY, March 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax'' or the ''Company''), an outcome-driven connected healthcare company,...
Parallax Receives Approval on its Registration Into U.S. Government's System for Award Management, (SAM)
16 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
Patented and FDA Approved Diagnostics Platform Subject of Application for Contract Grant with U.S. Center for Disease Control, (CDC) NEW YORK, NY, March 16, 2020 (GLOBE NEWSWIRE) -- via...
Parallax Health Management Announces Immediate Availability of its Good Health Outcomes Remote Patient Monitoring Mobile Application for Doctors and Their Patients Within the United States
12 mars 2020 07h00 HE
|
Parallax Health Sciences, Inc.
$8.3 Billion in Federal Emergency Funding from U.S. Congress Combined with Private Insurance Reimbursement Commitments Gives Boost to Telehealth Programs Addressing the COVID-19 Pandemic NEW...